Hyperbaric oxygen
Phase 3Small molecule
Hyperbaric oxygen is one of 168 small molecule programs targeting COVID-19. It is currently in Phase 3.
7
Indications
33
Total Trials
7
Active Trials
167
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
317 competitors in COVID-19
#DrugCompanyPhaseTrials
1Hyperbaric oxygen
IIntermountain Health Care, Inc.
Phase 3
Stivarga
BayerPreclinical
Aimovig
AmgenPreclinical
Aldactone
PfizerPreclinical
Nexavar
BayerPreclinical
Calciferol
Jazz PharmaceuticalsPreclinical
Activella
Eli LillyPreclinical
Angiomax
BBaxter Healthcare Corporation
Preclinical
Tricor
JJagotec
Preclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Injury3 trials
Brain Injury3 trials
Hyperbaric Oxygen Treatment to Treat Mild Traumatic Brain Injury (mTBI)/Persistent Post-Concussion Syndrome (PPCS)
Unknown status·LLouisiana State University Health Sciences Center in New Orleans·Phase 3·NCT02089594·59 enrolled
Stroke3 trials
COVID-192 trials
19 more indications
Treatment1 trial
Necrosis1 trial
Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain
Unknown status·—·N/A·NCT00087815·30 enrolled
Cystitis1 trial
Glioblastoma Multiforme1 trial
Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Unknown status·—·Phase 1/2·NCT00006460
Squamous Cell Carcinoma1 trial
Soft Tissue Sarcoma1 trial
Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study
Recruiting·—·Phase 4·NCT03144206·20 enrolled
Radiotherapy1 trial
Lymphedema1 trial
Osteoradionecrosis1 trial
Amputation1 trial
Hyperbaric Oxygen and Outcome After Below Knee Amputations
Terminated·—·Phase 1/2·NCT04717557·4 enrolled
AML1 trial
Unspecified2 trials
Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?
Active, not recruiting·—·Phase 4·NCT05804097·30 enrolled
Inner and Middle Ear Effects of Hyperbaric Oxygen Thrapy
Unknown status·—··NCT04186741·30 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Hyperbaric oxygen. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- IIntermountain Health Care, Inc.